Harriet Feilotter, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy
Current Oncology · 2026
Reply to "Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status".
American journal of clinical pathology · 2026
A Panel of Methylation-Based PCRs for Separating Mucinous Lung Adenocarcinomas From Gastrointestinal Metastases Involving the Lung.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2026

All 5 publications

Latest funding

Toward equity in cancer genetics: identifying racial disparities in cancer genetics services
CIHR · 2022 · Co-investigator
$734,400
A collaborative research program to integrate genomic and proteomic data for the identification of predictive biomarkers in bladder cancer
CIHR · 2009 · Principal investigator
$100,000

All 2 grants and awards

5 publications.

01

Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy

Kartolo A, Semenuk L, Feilotter H, Savage C, Boag A, Hopman W, Digby G, Mates M

Current Oncology20261 citationsOpen Access

DOI: 10.3390/curroncol33010042

02

Reply to "Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status".

Sabatini P, Zhang T, Boruvka N, Kim HS, Feilotter H, Stockley T, Chen C, Xia D

American journal of clinical pathology2026

DOI: 10.1093/ajcp/aqaf120 PMID: 41346081

03

A Panel of Methylation-Based PCRs for Separating Mucinous Lung Adenocarcinomas From Gastrointestinal Metastases Involving the Lung.

Cabanero M, Cao C, Sabatini P, Boruvka N, Kim HS, Zhang T, Feilotter H, Stockley T, Tsao M, Xia D

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2026

DOI: 10.1016/j.modpat.2026.101066 PMID: 42586242

04

Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status.

Sabatini P, Zhang T, Boruvka N, Kim HS, Feilotter H, Stockley T, Chen C, Xia D

American journal of clinical pathology20252 citations

DOI: 10.1093/ajcp/aqaf075 PMID: 40734655

05

The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction.

Kennedy SH, Downar J, Evans KR, Feilotter H, Lam RW, MacQueen GM, Milev R, Parikh SV, Rotzinger S, Soares C

Current pharmaceutical design201276 citations

DOI: 10.2174/138161212803523635 PMID: 22681173

Toward equity in cancer genetics: identifying racial disparities in cancer genetics services

Co-investigatorCIHR2022Project Grant

Principal investigators: Bombard, Yvonne

Keywords: Chart Review; Equity; Genetics Health Services; Health Disparities; Healthcare Access; Racialized Communities

$734,400

A collaborative research program to integrate genomic and proteomic data for the identification of predictive biomarkers in bladder cancer

Principal investigatorCIHR2009Catalyst Grant: Bioinformatics Approaches to Cancer Research

Principal investigators: Zhang, Zhaolei; Evans, Kenneth R; Feilotter, Harriet E; Squire, Jeremy A; Van Der Kwast, Theodorus H

Keywords: Biomarkers; Bionformatics; Bladder Cancer; Cancer Diagnostics; Genomics; Proteomics

$100,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Department of Psychiatry
Department of Laboratory Medicine & Pathobiology
Department of Oncology
Department of Medicine
Pathology
Department of Medical Biophysics

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Feilotter, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]